Search results
Results from the WOW.Com Content Network
There was preliminary evidence that combining hydroxychloroquine and azithromycin for treating non-hospitalized ("outpatient") people with COVID-19 infection with multiple comorbidities was effective, [67] but this evidence was not confirmed by later studies: co-administration of chloroquine or hydroxychloroquine with azithromycin has been ...
One of the most serious side effects is retinopathy (generally with chronic use). [ 3 ] [ 20 ] People taking 400 mg of hydroxychloroquine or less per day generally have a negligible risk of macular toxicity, whereas the risk begins to increase when a person takes the medication over five years or has a cumulative dose of more than 1000 grams.
And these are the most common potential side effects of the COVID-19 vaccine: Pain, swelling, and redness on the arm where the shot was given. Fatigue. Headache. Muscle pain. Chills. Nausea.
Hydroxycut is a brand of dietary supplements that is marketed as a weight loss aid. Hydroxycut was originally developed and manufactured by MuscleTech Research and Development; MuscleTech was sold to Iovate Health Sciences in 2003–2004 and declared bankruptcy in 2005; Iovate continues to use MuscleTech as a brand to market Hydroxycut.
The updated COVID-19 vaccine is now available. Infectious disease doctors recommend being smart about the timing of your shot. You can expect similar side effects to the previous vaccines if you ...
Some authors have reflected on the possible effects of the COVID-19 quarantine on children and adolescents. Wang and colleagues highlight the need for awareness of the quarantine's potential effects on children's mental health, and the importance for governments, non-governmental organizations, the community, schools, and parents to act to ...
This is because “the risk of getting COVID-19 is less likely in the weeks to months following a SARS-CoV-2 infection.” The vaccines are currently available and can be taken now, agrees Dr ...
Individuals may experience distress from quarantine, travel restrictions, side effects of treatment, or fear of the infection itself. To address these concerns, the National Health Commission of China published a national guideline for psychological crisis intervention on 27 January 2020.